United Capital Financial Advisers, LLC Ampio Pharmaceuticals, Inc. Transaction History

United Capital Financial Advisers, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	BUY	$0.16 - $0.47 $2,079 - $6,109	12,999 Added 20.63%	76,000 $13,000
Q1 2022 May 16, 2022	BUY	$0.42 - $0.62 $2,520 - $3,720	6,001 Added 10.53%	63,001 $30,000
Q3 2021 Nov 15, 2021	BUY	$1.21 - $1.8 $1,936 - $2,880	1,600 Added 2.89%	57,000 $95,000
Q1 2021 May 14, 2021	BUY	$1.36 - $2.49 $544 - $996	400 Added 0.73%	55,400 $94,000
Q3 2020 Nov 13, 2020	BUY	$0.61 - $1.17 $1,287 - $2,468	2,110 Added 3.99%	55,000 $53,000
Q2 2020 Aug 13, 2020	BUY	$0.47 - $0.72 $1,686 - $2,584	3,589 Added 7.28%	52,890 $34,000
Q1 2020 May 15, 2020	BUY	$0.36 - $0.74 $577 - $1,186	1,603 Added 3.36%	49,301 $20,000
Q4 2019 Feb 14, 2020	BUY	$0.35 - $0.58 $465 - $771	1,330 Added 2.87%	47,698 $28,000
Q3 2019 Nov 14, 2019	BUY	$0.38 - $0.52 $4,630 - $6,336	12,185 Added 35.65%	46,368 $23,000
Q4 2018 Feb 14, 2019	BUY	$0.39 - $0.7 $3,022 - $5,425	7,750 Added 29.32%	34,183 $13,000
Q3 2018 Nov 14, 2018	BUY	$0.44 - $3.02 $1,415 - $9,715	3,217 Added 13.86%	26,433 $13,000
Q2 2018 Aug 14, 2018	BUY	$1.66 - $3.82 $4,835 - $11,127	2,913 Added 14.35%	23,216 $51,000
Q1 2018 May 15, 2018	BUY	$2.16 - $3.48 $3,954 - $6,371	1,831 Added 9.91%	20,303 $69,000
Q4 2017 Feb 13, 2018	BUY	$0.68 - $4.19 $2,246 - $13,843	3,304 Added 21.78%	18,472 $75,000
Q3 2017 Nov 14, 2017	BUY	$0.38 - $0.66 $5,763 - $10,010	15,168	15,168 $9,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Market Cap $2.26M
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of United Capital Financial Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on United Capital Financial Advisers, LLC with notifications on news.